论文部分内容阅读
肺高血压包括肺动脉高压、肺静脉高压和混合性肺高血压,其特征是肺动脉压力增高,伴或不伴有小肺动脉病变的恶性肺血管疾病。近年来肺高血压以其越来越高的致残率和病死率,引起医学界的高度重视。本病的基础治疗(吸氧、强心、利尿、抗凝)常被忽视,尤其是抗凝治疗。文章对肺高血压抗凝治疗的意义及注意事项,对华法林、阿斯匹林和低分子量肝素等抗凝药物治疗的研究进展进行梳理分析,为肺高血压的抗凝治疗提供参考和思路。
Pulmonary hypertension includes pulmonary hypertension, pulmonary hypertension and mixed pulmonary hypertension, which is characterized by an increase in pulmonary artery pressure with or without malignant pulmonary vascular disease of small pulmonary artery disease. In recent years, its higher and higher morbidity and mortality of pulmonary hypertension have aroused great attention of the medical community. The basic treatment of this disease (oxygen, cardiac, diuretic, anticoagulant) are often overlooked, especially anticoagulant therapy. This paper describes the significance and precautions of anticoagulant therapy for pulmonary hypertension, combing the research progress of anticoagulant drugs such as warfarin, aspirin and low molecular weight heparin, providing reference for anticoagulant therapy of pulmonary hypertension and Ideas.